BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Feng H, Zhang H, Deng J, Wang L, He Y, Wang S, Seyedtabaei R, Wang Q, Liu L, Galipeau J, Compans RW, Wang BZ. Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs. Sci Rep 2015;5:11856. [PMID: 26150163 DOI: 10.1038/srep11856] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Zhao C, Ao Z, Yao X. Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection. Vaccines (Basel) 2016;4:E2. [PMID: 26805898 DOI: 10.3390/vaccines4010002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
2 Sun X, Zhang H, Xu S, Shi L, Dong J, Gao D, Chen Y, Feng H. Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses. Virol J 2017;14:163. [PMID: 28830557 DOI: 10.1186/s12985-017-0831-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
3 Zhu W, Dong C, Wei L, Wang BZ. Promising Adjuvants and Platforms for Influenza Vaccine Development. Pharmaceutics 2021;13:68. [PMID: 33430259 DOI: 10.3390/pharmaceutics13010068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Littauer EQ, Mills LK, Brock N, Esser ES, Romanyuk A, Pulit-Penaloza JA, Vassilieva EV, Beaver JT, Antao O, Krammer F, Compans RW, Prausnitz MR, Skountzou I. Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza. J Control Release 2018;276:1-16. [PMID: 29496540 DOI: 10.1016/j.jconrel.2018.02.033] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
5 Gao D, Chen Y, Han D, Qi Q, Sun X, Zhang H, Feng H, Wang M. Membrane-anchored stalk domain of influenza HA enhanced immune responses in mice. Microb Pathog 2017;113:421-6. [PMID: 29174687 DOI: 10.1016/j.micpath.2017.11.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
6 Vzorov AN, Uryvaev LV. Requirements for the Induction of Broadly Neutralizing Antibodies against HIV-1 by Vaccination. Mol Biol 2017;51:819-29. [DOI: 10.1134/s0026893317060176] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Mohan T, Kim J, Berman Z, Wang S, Compans RW, Wang BZ. Co-delivery of GPI-anchored CCL28 and influenza HA in chimeric virus-like particles induces cross-protective immunity against H3N2 viruses. J Control Release 2016;233:208-19. [PMID: 27178810 DOI: 10.1016/j.jconrel.2016.05.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
8 Schäfer B, Orbán E, Fiser G, Marton A, Vizler C, Tömböly C. Semisynthesis of membrane-anchored cholesteryl lipoproteins on live cell surface by azide–alkyne click reaction. Tetrahedron Letters 2016;57:868-73. [DOI: 10.1016/j.tetlet.2016.01.041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Matabaro E, He Z, Liu YS, Zhang HJ, Gao XD, Fujita M. Molecular switching system using glycosylphosphatidylinositol to select cells highly expressing recombinant proteins. Sci Rep 2017;7:4033. [PMID: 28642584 DOI: 10.1038/s41598-017-04330-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Heider S, Dangerfield JA, Metzner C. Biomedical applications of glycosylphosphatidylinositol-anchored proteins. J Lipid Res 2016;57:1778-88. [PMID: 27542385 DOI: 10.1194/jlr.R070201] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
11 Gao Y, Wijewardhana C, Mann JFS. Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1. Front Immunol 2018;9:345. [PMID: 29541072 DOI: 10.3389/fimmu.2018.00345] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
12 Mohan T, Zhu W, Wang Y, Wang BZ. Applications of chemokines as adjuvants for vaccine immunotherapy. Immunobiology 2018;223:477-85. [PMID: 29246401 DOI: 10.1016/j.imbio.2017.12.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
13 Plummer JR, McGettigan JP. Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses. PLoS Negl Trop Dis 2019;13:e0007800. [PMID: 31725816 DOI: 10.1371/journal.pntd.0007800] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
14 Cossette B, Kelly SH, Collier JH. Intranasal Subunit Vaccination Strategies Employing Nanomaterials and Biomaterials. ACS Biomater Sci Eng 2021;7:1765-79. [DOI: 10.1021/acsbiomaterials.0c01291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Dong C, Wang B. Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats. Advanced NanoBiomed Research 2022;2:2100122. [DOI: 10.1002/anbr.202100122] [Reference Citation Analysis]
16 Mohan T, Berman Z, Kang SM, Wang BZ. Sequential immunizations with a panel of HIV-1 Env virus-like particles coach immune system to make broadly neutralizing antibodies. Sci Rep 2018;8:7807. [PMID: 29773829 DOI: 10.1038/s41598-018-25960-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]